Global Blood Therapeutics (GBT) announced Tuesday morning that it has been granted a Breakthrough Therapy Designation from the FDA for voxelotor, for the treatment of sickle cell disease.
from RTT - Before the Bell http://ift.tt/2CLqDkr
via IFTTT
No comments:
Post a Comment